{
    "organizations": [],
    "uuid": "8a9b54d98f7a2f1d471945a1ef526c36ab89f3b8",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-oxford-biomedica-says-kymriah-rece/brief-oxford-biomedica-says-kymriah-receives-priority-review-for-adult-dlbcl-idUSFWN1PC0M8",
    "ord_in_thread": 0,
    "title": "BRIEF-Oxford Biomedica Says ‍Kymriah Receives Priority Review For Adult DLBCL​",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 17 (Reuters) - Oxford Biomedica Plc:\n* SAYS ‍KYMRIAH RECEIVES PRIORITY REVIEW FOR ADULT DLBCL​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-01-17T15:42:00.000+02:00",
    "crawled": "2018-01-18T16:30:37.008+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "oxford",
        "biomedica",
        "plc",
        "say",
        "receives",
        "priority",
        "review",
        "adult",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}